Skip to main content
. Author manuscript; available in PMC: 2020 Nov 30.
Published in final edited form as: J Med Chem. 2019 Jul 3;62(14):6814–6823. doi: 10.1021/acs.jmedchem.9b00825

Figure 5.

Figure 5.

Optimization of a fluorescence polarization assay to assess BTN3A1 ligand binding. (A) Structure of the GDP-BODIPY probe. Optimization of the fluorescence polarization assay involved varying probe (B-D) and BFI (E) concentrations. pH (F) and divalent cation (G) effects were also investigated. Data represents mean +/− SD.